Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone

por Ben-Joseph, Rami, Bell, Jill A., Brixner, Diana, Kansal, Anuraag, Paramore, Clark, Chitnis, Abhishek, Holly, Pamela, S. Burgoyne, Douglas
Publicado 2016

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review

por Mearns, Elizabeth S, Bell, Jill A, Galaznik, Aaron, Puglielli, Stefanie M, Cichewicz, Allie B, Boulanger, Talia, Garcia-Ribas, Ignacio
Publicado 2018

Patient‐Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

por Chari, Ajai, Romanus, Dorothy, DasMahapatra, Pronabesh, Hoole, Michael, Lowe, Maria, Curran, Chris, Campbell, Scott, Bell, Jill A.
Publicado 2019

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

por Rifkin, Robert M., Bell, Jill A., DasMahapatra, Pronabesh, Hoole, Michael, Lowe, Maria, Curran, Chris, Campbell, Scott, Hou, Peijie, Romanus, Dorothy
Publicado 2019

Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30

por Regnault, Antoine, Pompilus, Farrah, Ciesluk, Anna, Mazerolle, Flora, Bejar, Rafael, Fram, Robert J., Faller, Douglas V., Marquis, Patrick, Bell, Jill A.
Publicado 2021

Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer...

por Zhu, Yanyan, Jean‐Baptiste, Milenka, Lenderking, William R., Bell, Jill A., Revicki, Dennis A., Lin, Huamao M., Brake, Rachael, Reeve, Bryce B.
Publicado 2022

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States

por Bell, Jill A., Galaznik, Aaron, Blazer, Marlo, Shih, Huai-Che, Farrelly, Eileen, Ogbonnaya, Augustina, Eaddy, Michael, Fram, Robert J., Faller, Douglas V.
Publicado 2018

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia,...

por Bell, Jill A., Galaznik, Aaron, Pompilus, Farrah, Strzok, Sara, Bejar, Rafael, Scipione, Fatima, Fram, Robert J., Faller, Douglas V., Cano, Stefan, Marquis, Patrick
Publicado 2019

Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α Overexpression Increases Lipid Oxidation in Myocytes From Extremely Obese Individuals

por Consitt, Leslie A., Bell, Jill A., Koves, Timothy R., Muoio, Deborah M., Hulver, Matthew W., Haynie, Kimberly R., Dohm, G. Lynis, Houmard, Joseph A.
Publicado 2010